Evommune, Inc. (EVMN)
12.66
-0.57
(-4.31%)
USD |
NYSE |
Aug 31, 16:00
12.65
-0.01
(-0.08%)
Pre-Market: 06:46
Evommune Free Cash Flow : -74.65M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -74.65M |
| March 31, 2026 | -80.36M |
| December 31, 2025 | -76.68M |
| Date | Value |
|---|---|
| September 30, 2025 | -86.10M |
| June 30, 2025 | -84.98M |
| March 31, 2025 | -63.67M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| MapLight Therapeutics, Inc. | -175.12M |
| Mineralys Therapeutics, Inc. | -138.80M |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Oncolytics Biotech, Inc. | -26.53M |
| Sangamo Therapeutics, Inc. | -90.46M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.32M |
| Cash from Investing (Quarterly) | 31.29M |
| Cash from Financing (Quarterly) | 0.532M |
| Free Cash Flow Per Share (Quarterly) | -0.5673 |
| Free Cash Flow to Equity (Quarterly) | -20.01M |
| Free Cash Flow to Firm (Quarterly) | -20.50M |
| Free Cash Flow Yield | -17.75% |